On the public citation graph

Ivermectin and COVID-19: Keeping Rigor in Times of Urgency

0 signed · 198 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 25 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-21): 10.1016/j.ijantimicag.2020.105949 (notice 2024-12-16).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.4742openalex-snapshot

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

inferredcites →https://doi.org/10.1007/978-1-4612-3626-9_8openalex-snapshot

Metabolism and Tissue Residues

inferredcites →https://doi.org/10.1007/s00705-015-2653-2openalex-snapshot

Ivermectin inhibits porcine reproductive and respiratory syndrome virus in cultured porcine alveolar macrophages

inferredcites →https://doi.org/10.1016/j.antiviral.2013.06.002openalex-snapshot

Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

inferredcites →https://doi.org/10.1016/j.antiviral.2015.12.012openalex-snapshot

Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses

inferredcites →https://doi.org/10.1016/j.antiviral.2020.104760openalex-snapshot

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

inferredcites →https://doi.org/10.1016/j.antiviral.2020.104787openalex-snapshot

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

inferredcites →https://doi.org/10.1016/j.bbi.2016.03.010openalex-snapshot

The blood-brain barrier in systemic inflammation

inferredcites →https://doi.org/10.1016/j.chom.2016.07.004openalex-snapshot

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

inferredcites →https://doi.org/10.1016/j.ijantimicag.2020.105949openalex-snapshot

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

inferredcites →https://doi.org/10.1016/j.medmal.2020.03.006openalex-snapshot

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

inferredcites →https://doi.org/10.1016/j.pt.2014.07.005openalex-snapshot

Ivermectin: panacea for resource-poor communities?

inferredcites →https://doi.org/10.1016/j.vetpar.2004.11.028openalex-snapshot

Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat

inferredcites →https://doi.org/10.1016/s0006-2952(99)00026-xopenalex-snapshot

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833

inferredcites →https://doi.org/10.1042/bj20120150openalex-snapshot

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

inferredcites →https://doi.org/10.1093/jac/dks147openalex-snapshot

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

inferredcites →https://doi.org/10.1128/aac.01089-12openalex-snapshot

Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, In Vitro

inferredcites →https://doi.org/10.1148/radiol.2020201187openalex-snapshot

COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features

inferredcites →https://doi.org/10.1177/009127002237994openalex-snapshot

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

inferredcites →https://doi.org/10.1186/s12936-017-1801-4openalex-snapshot

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety

inferredcites →https://doi.org/10.1371/journal.pntd.0001883openalex-snapshot

Relative Neurotoxicity of Ivermectin and Moxidectin in Mdr1ab (−/−) Mice and Effects on Mammalian GABA(A) Channel Activity

inferredcites →https://doi.org/10.1371/journal.pntd.0003996openalex-snapshot

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment

inferredcites →https://doi.org/10.3785/j.issn.1008-9292.2020.03.03openalex-snapshot

[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

inferredcites →https://doi.org/10.4269/ajtmh.17-0042openalex-snapshot

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

inferredcites →https://doi.org/10.4269/ajtmh.19-0620openalex-snapshot

A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3649412openalex-extracted

Early Diagnosis and Early Management Proposal in Dengue Infection: New Normal to Applied Strategy for COVID-19 Infection

inferred← citeshttps://doi.org/10.1002/9781394168033.ch3openalex-snapshot

Ivermectin as a Repurposed Drug for COVID‐19

inferred← citeshttps://doi.org/10.1002/jcp.30055openalex-snapshot

Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment

inferred← citeshttps://doi.org/10.1002/jmv.26610openalex-snapshot

Pathogenesis‐directed therapy of 2019 novel coronavirus disease

inferred← citeshttps://doi.org/10.1002/jmv.27122openalex-snapshot

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

inferred← citeshttps://doi.org/10.1002/slct.202103301openalex-snapshot

An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS‐CoV‐2 Activity

inferred← citeshttps://doi.org/10.1007/978-3-031-80369-7_9openalex-snapshot

Pharmacotherapy: Traditional Medication and Complementary Alternative Therapies

inferred← citeshttps://doi.org/10.1007/s00204-021-03025-zopenalex-snapshot

Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects

inferred← citeshttps://doi.org/10.1007/s10517-021-05125-3openalex-snapshot

Antiviral Drug Ivermectin at Nanomolar Concentrations Inhibits Glycine-Induced Chloride Current in Rat Hippocampal Neurons

inferred← citeshttps://doi.org/10.1007/s11270-022-05744-0openalex-snapshot

Effects of Avermectins on the Environment Based on Its Toxicity to Plants and Soil Invertebrates—a Review

inferred← citeshttps://doi.org/10.1007/s12639-023-01608-4openalex-snapshot

Ivermectin modulated cerebral γ-aminobutyric acid (GABA) and reduced the number of chronic Toxoplasma gondii cysts significantly in the brains of immunocompromised mice

inferred← citeshttps://doi.org/10.1007/s13337-021-00696-1openalex-snapshot

Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s)

inferred← citeshttps://doi.org/10.1007/s13596-024-00761-2openalex-snapshot

Phyto-chemical, analytical evaluation and biological attributes of rare medicinal species of flowering shrub Bauhinia racemosa L.

inferred← citeshttps://doi.org/10.1007/s13665-023-00302-3openalex-snapshot

Current and Emerging Therapies for COVID-19 in Lung Transplantation

inferred← citeshttps://doi.org/10.1007/s13721-021-00299-2openalex-snapshot

In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV

inferred← citeshttps://doi.org/10.1007/s40995-022-01349-8openalex-snapshot

Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of COVID-19 Outpatients: A Cross-Sectional Study

inferred← citeshttps://doi.org/10.1007/s43440-020-00195-yopenalex-snapshot

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

inferred← citeshttps://doi.org/10.1007/s43440-020-00204-0openalex-snapshot

SARS-CoV-2 therapeutics: how far do we stand from a remedy?

inferred← citeshttps://doi.org/10.1016/b978-0-12-818619-0.00053-8openalex-snapshot

COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2

inferred← citeshttps://doi.org/10.1016/b978-0-12-824315-2.00269-4openalex-snapshot

Avermectin

inferred← citeshttps://doi.org/10.1016/b978-0-12-824409-8.00002-3openalex-snapshot

Treatment and therapeutic agents

inferred← citeshttps://doi.org/10.1016/b978-0-323-85156-5.00013-4openalex-snapshot

FDA Coronavirus Treatment Acceleration Program: approved drugs and those in clinical trials

inferred← citeshttps://doi.org/10.1016/b978-0-323-90595-4.00002-9openalex-snapshot

Lines of Treatment of COVID-19 Infection

inferred← citeshttps://doi.org/10.1016/j.bbadis.2021.166294openalex-snapshot

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111518openalex-snapshot

Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111642openalex-snapshot

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment

inferred← citeshttps://doi.org/10.1016/j.carrev.2022.06.004openalex-snapshot

The Effect of Ivermectin on Cases of COVID-19

inferred← citeshttps://doi.org/10.1016/j.cegh.2022.101074openalex-snapshot

The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?

inferred← citeshttps://doi.org/10.1016/j.clindermatol.2021.01.020openalex-snapshot

Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?

inferred← citeshttps://doi.org/10.1016/j.clinthera.2021.04.007openalex-snapshot

Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial

inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100959openalex-snapshot

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112647openalex-snapshot

COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus

inferred← citeshttps://doi.org/10.1016/j.eplepsyres.2021.106675openalex-snapshot

Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29606openalex-snapshot

Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry

inferred← citeshttps://doi.org/10.1016/j.idcr.2022.e01446openalex-snapshot

Intravenous veterinary ivermectin in a COVID-19 patient causing neurotoxicity

inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107228openalex-snapshot

Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective

inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108004openalex-snapshot

Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study

inferred← citeshttps://doi.org/10.1016/j.jiph.2021.04.011openalex-snapshot

Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review

inferred← citeshttps://doi.org/10.1016/j.mcpsp.2022.100346openalex-snapshot

Clinical protocol for early treatment of COVID-19 in a real-world scenario: Results of a series of patients

inferred← citeshttps://doi.org/10.1016/j.onehlt.2020.100148openalex-snapshot

COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution

inferred← citeshttps://doi.org/10.1016/j.pt.2020.10.005openalex-snapshot

Ivermectin: An Anthelmintic, an Insecticide, and Much More

inferred← citeshttps://doi.org/10.1016/j.retram.2021.103309openalex-snapshot

Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection

inferred← citeshttps://doi.org/10.1016/j.sciaf.2021.e00970openalex-snapshot

Structure-based virtual screening and molecular dynamics simulation studies to discover new SARS-CoV-2 main protease inhibitors

inferred← citeshttps://doi.org/10.1016/j.scitotenv.2021.152691openalex-snapshot

Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination

inferred← citeshttps://doi.org/10.1021/acs.jnatprod.0c00968openalex-snapshot

Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2

inferred← citeshttps://doi.org/10.1038/s41598-020-74084-yopenalex-snapshot

Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

inferred← citeshttps://doi.org/10.1039/d1cp02967copenalex-snapshot

Microscopic interactions between ivermectin and key human and viral proteins involved in SARS-CoV-2 infection

inferred← citeshttps://doi.org/10.1080/07391102.2020.1802345openalex-snapshot

Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2

inferred← citeshttps://doi.org/10.1080/10428194.2020.1786559openalex-snapshot

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

inferred← citeshttps://doi.org/10.1080/1062936x.2021.1932583openalex-snapshot

QSAR analysis of the acute toxicity of avermectins towards Tetrahymena pyriformis

inferred← citeshttps://doi.org/10.1080/10837450.2022.2121840openalex-snapshot

Ivermectin: recent approaches in the design of novel veterinary and human medicines

inferred← citeshttps://doi.org/10.1080/13102818.2020.1775118openalex-snapshot

Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens

inferred← citeshttps://doi.org/10.1080/13102818.2020.1847683openalex-snapshot

The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19

inferred← citeshttps://doi.org/10.1080/14787210.2021.1864327openalex-snapshot

Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress

inferred← citeshttps://doi.org/10.1080/17460441.2021.1863943openalex-snapshot

Can drug repurposing strategies be the solution to the COVID-19 crisis?

inferred← citeshttps://doi.org/10.1080/20477724.2023.2240088openalex-snapshot

Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

inferred← citeshttps://doi.org/10.1093/chromsci/bmad092openalex-snapshot

Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs

inferred← citeshttps://doi.org/10.1093/cid/ciab591openalex-snapshot

Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials

inferred← citeshttps://doi.org/10.1093/ofid/ofab318openalex-snapshot

Ivermectin for the Treatment of COVID-19 Disease: Too Good to Pass Up or Too Good to Be True?

inferred← citeshttps://doi.org/10.1093/oxfimm/iqad001openalex-snapshot

Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2

inferred← citeshttps://doi.org/10.1097/ccm.0000000000004895openalex-snapshot

The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness

inferred← citeshttps://doi.org/10.1097/inf.0000000000003916openalex-snapshot

Investigating the Possible Reasons for the Low Reported Morbidity and Mortality of COVID-19 in African Countries: An Integrative Review

inferred← citeshttps://doi.org/10.1097/mjt.0000000000001490openalex-snapshot

Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status

inferred← citeshttps://doi.org/10.1097/mop.0000000000000983openalex-snapshot

Acute severe respiratory syndrome coronavirus-2 treatment overview for pediatrics

inferred← citeshttps://doi.org/10.1101/2021.11.01.466865openalex-snapshot

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19

inferred← citeshttps://doi.org/10.1101/2022.12.28.522082openalex-snapshot

Erythromycin, Retapamulin, Pyridoxine, Folic acid and Ivermectin dose dependently inhibit cytopathic effect, Papain-like Protease and M PRO of SARS-CoV-2

inferred← citeshttps://doi.org/10.1101/2023.01.30.23285173openalex-snapshot

Current Status and Emerging Trends of COVID-19-related Studies in Seven ‘Tropical Medicine’-entitled Journals

inferred← citeshttps://doi.org/10.1111/cts.12824openalex-snapshot

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19

inferred← citeshttps://doi.org/10.1111/eci.13763openalex-snapshot

A comprehensive review of adverse events to drugs used in COVID‐19 patients: Recent clinical evidence

inferred← citeshttps://doi.org/10.1111/epi.17511openalex-snapshot

Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?

inferred← citeshttps://doi.org/10.1111/febs.16662openalex-snapshot

A guide to COVID ‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV ‐2 infection

inferred← citeshttps://doi.org/10.1111/joim.13499openalex-snapshot

COVID‐19 in Latin America and the Caribbean: Two years of the pandemic

inferred← citeshttps://doi.org/10.1128/cmr.00109-21openalex-snapshot

SARS-CoV-2 Antiviral Therapy

inferred← citeshttps://doi.org/10.1128/msystems.00233-21openalex-snapshot

Identification and Development of Therapeutics for COVID-19

inferred← citeshttps://doi.org/10.1136/bmjopen-2021-058572openalex-snapshot

Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study

inferred← citeshttps://doi.org/10.1136/postgradmedj-2020-138791openalex-snapshot

Review on therapeutic targets for COVID-19: insights from cytokine storm

inferred← citeshttps://doi.org/10.11604/pamj.2020.37.352.25254openalex-snapshot

Unexpected low burden of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa region despite disastrous predictions: reasons and perspectives

inferred← citeshttps://doi.org/10.1177/15353702221099579openalex-snapshot

Potential therapeutic effects of Ivermectin in COVID-19

inferred← citeshttps://doi.org/10.1186/s40001-022-00645-8openalex-snapshot

Repurposing the drug, ivermectin, in COVID-19: toxicological points of view

inferred← citeshttps://doi.org/10.1371/journal.pone.0242184openalex-snapshot

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

inferred← citeshttps://doi.org/10.14218/erhm.2020.00059openalex-snapshot

A Proposal of Early Diagnosis and Early Management in Dengue Infection and Possible COVID-19

inferred← citeshttps://doi.org/10.14745/ccdr.v47i78a04openalex-snapshot

Ivermectin treatment for Strongyloides infection in patients with COVID-19

inferred← citeshttps://doi.org/10.14745/ccdr.v47i78a04fopenalex-snapshot

Traitement à l’ivermectine pour l’infection à Strongyloides chez les patients atteints de COVID-19

inferred← citeshttps://doi.org/10.1515/dmpt-2022-0130openalex-snapshot

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling

inferred← citeshttps://doi.org/10.15252/emmm.202114122openalex-snapshot

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin

inferred← citeshttps://doi.org/10.1590/0102-311xen001022openalex-snapshot

Sales of “COVID kit” drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency

inferred← citeshttps://doi.org/10.18176/jiaci.0588openalex-snapshot

Treating COVID-19: Review of Drug Hypersensitivity Reactions

inferred← citeshttps://doi.org/10.20453/stv.v8i1.3789openalex-snapshot

Ivermectina dentro del protocolo de tratamiento para la COVID-19 en Perú: Uso sin evidencia científica

inferred← citeshttps://doi.org/10.21203/rs.3.rs-379291/v1openalex-snapshot

Highly-transmissible Variants of SARS-CoV-2 May Be More Susceptible to Drug Therapy Than Wild Type Strains

inferred← citeshttps://doi.org/10.21307/pm-2020.59.3.15openalex-snapshot

Covid-19 Therapy: What Have We Learned In 8 Months?

inferred← citeshttps://doi.org/10.21608/esctj.2021.105858.1004openalex-snapshot

Possible Hepatotoxic Effects In Adult Male Albino Rats On Combination Of Ivermectin And Paracetamol Drugs Used In COVID-19 Infection Management Protocol

inferred← citeshttps://doi.org/10.2174/0113894501336800250220051811openalex-snapshot

Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment

inferred← citeshttps://doi.org/10.2174/18743722-v16-e2205190openalex-snapshot

Intranasal Ivermectin Spray, the Sunscreen to COVID-19

inferred← citeshttps://doi.org/10.2174/2213337210666230809141610openalex-snapshot

More Widespread use of Ivermectin for the Treatment of COVID-19 Infection could have Saved Many

inferred← citeshttps://doi.org/10.2174/2666796701999201204122819openalex-snapshot

Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials

inferred← citeshttps://doi.org/10.21931/rb/2020.05.03.2openalex-snapshot

Pseudoscientific Treatments in the COVID-19 Pandemic: Flattening the "Infodemic" Curve Also Saves Lives

inferred← citeshttps://doi.org/10.2196/19583openalex-snapshot

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

inferred← citeshttps://doi.org/10.2196/21648openalex-snapshot

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach

inferred← citeshttps://doi.org/10.2217/fvl-2021-0160openalex-snapshot

Can Anti-Parasitic Drugs Help Control COVID-19?

inferred← citeshttps://doi.org/10.22270/ajprd.v9i1.910openalex-snapshot

Covid-19: A Pharmacotherapeutic Perspective

inferred← citeshttps://doi.org/10.2307/j.ctv2tbwqd5.12openalex-snapshot

Ethical research in public policy

inferred← citeshttps://doi.org/10.23902/trkjnat.901480openalex-snapshot

In vitro CYTOTOXIC EFFECTS OF SOME COVID-19 DRUGS ON LUNG CANCER CELLS

inferred← citeshttps://doi.org/10.23936/pfr.v5i2.158openalex-snapshot

El coronavirus y la crisis de la medicina

inferred← citeshttps://doi.org/10.23936/pfr.v5i2.159openalex-snapshot

Covid 19

inferred← citeshttps://doi.org/10.24108/preprints-3112470openalex-snapshot

Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

inferred← citeshttps://doi.org/10.24265/horizmed.2021.v21n2.01openalex-snapshot

La COVID-19, la ciencia y la pseudociencia, un yin-yang peligroso

inferred← citeshttps://doi.org/10.25100/iyc.v23i1.10290openalex-snapshot

Research on repurposed antivirals currently available in Colombia as treatment alternatives for COVID-19

inferred← citeshttps://doi.org/10.26719/emhj.21.010openalex-snapshot

Infodemic, self-medication and stockpiling: a worrying combination

inferred← citeshttps://doi.org/10.28933/gjmb-2021-06-1805openalex-snapshot

THE USE OF ANTIPARASITIC DRUGS AS A TREATMENT FOR COVID-19: A NARRATIVE REVIEW

inferred← citeshttps://doi.org/10.28998/rpss.v5i2.11048openalex-snapshot

Fake News: Combata esse vírus! Projeto Fake Não!

inferred← citeshttps://doi.org/10.29309/tpmj/2021.28.04.6010openalex-snapshot

Potential pharmacological and non-pharmacological interventions for coronavirus disease 2019 (COVID-19): A Narrative Review.

inferred← citeshttps://doi.org/10.29327/533647openalex-snapshot

COVID-19 - O VÍRUS QUE MOVIMENTOU A CIÊNCIA - VOLUME 1

inferred← citeshttps://doi.org/10.30442/ahr.0801-01-152openalex-snapshot

Predictors of COVID-19 Vaccine Acceptance Among Nigerian Medical Doctors

inferred← citeshttps://doi.org/10.30895/2312-7821-2022-10-1-19-33openalex-snapshot

Ivermectin: Evaluation of Efficacy and Safety in COVID-19

inferred← citeshttps://doi.org/10.31219/osf.io/3bj74openalex-snapshot

Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

inferred← citeshttps://doi.org/10.31219/osf.io/gkeadopenalex-snapshot

Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

inferred← citeshttps://doi.org/10.31222/osf.io/3whptopenalex-snapshot

Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

inferred← citeshttps://doi.org/10.3329/imcjms.v14i2.52826openalex-snapshot

Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study

inferred← citeshttps://doi.org/10.33320/maced.pharm.bull.2023.69.03.035openalex-snapshot

Development and characterization of ivermectin loaded liposomes prepared by lipid film hydration and ethanol injection method

inferred← citeshttps://doi.org/10.33448/rsd-v10i12.20486openalex-snapshot

Conhecimento sobre o tratamento precoce e as medidas de prevenção da Covid-19 em moradores do Estado do Pará-Brasil

inferred← citeshttps://doi.org/10.33448/rsd-v9i8.6234openalex-snapshot

Ivermectina como possível aliado no tratamento da COVID-19: perspectivas acerca de sua ação antiviral

inferred← citeshttps://doi.org/10.3389/fcimb.2023.1273982openalex-snapshot

Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2

inferred← citeshttps://doi.org/10.3389/fimmu.2021.683694openalex-snapshot

Will Auranofin Become a Golden New Treatment Against COVID-19?

inferred← citeshttps://doi.org/10.3389/fimmu.2021.752227openalex-snapshot

Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics

inferred← citeshttps://doi.org/10.3389/fphar.2021.666348openalex-snapshot

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients

inferred← citeshttps://doi.org/10.3389/fpubh.2022.788972openalex-snapshot

Ivermectin and the Integrity of Healthcare Evidence During COVID-19

inferred← citeshttps://doi.org/10.3390/antibiotics10040381openalex-snapshot

Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria

inferred← citeshttps://doi.org/10.3390/antibiotics14050459openalex-snapshot

Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole

inferred← citeshttps://doi.org/10.3390/biology10101064openalex-snapshot

Human Drug Pollution in the Aquatic System: The Biochemical Responses of Danio rerio Adults

inferred← citeshttps://doi.org/10.3390/chemistry4020019openalex-snapshot

Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine

inferred← citeshttps://doi.org/10.3390/covid2010005openalex-snapshot

Low Selectivity Indices of Ivermectin and Macrocyclic Lactones on SARS-CoV-2 Replication In Vitro

inferred← citeshttps://doi.org/10.3390/ijms22041737openalex-snapshot

Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics

inferred← citeshttps://doi.org/10.3390/ijms241612782openalex-snapshot

The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases

inferred← citeshttps://doi.org/10.3390/microorganisms10030633openalex-snapshot

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

inferred← citeshttps://doi.org/10.3390/pathogens10060636openalex-snapshot

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2

inferred← citeshttps://doi.org/10.3390/ph13080196openalex-snapshot

Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects

inferred← citeshttps://doi.org/10.3390/pharmaceutics13010081openalex-snapshot

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters

inferred← citeshttps://doi.org/10.3390/pr8080937openalex-snapshot

The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19

inferred← citeshttps://doi.org/10.34119/bjhrv4n3-053openalex-snapshot

Drogas off label na COVID-19: Mecanismo de ação e atualizações The use of off label drugs for COVID-19: Mechanisms of action and updates

inferred← citeshttps://doi.org/10.34172/ps.2020.82openalex-snapshot

A Summary of Coronavirus Disease 2019: What We Should Know?

inferred← citeshttps://doi.org/10.35366/99417openalex-snapshot

Actualización del manejo clínico de COVID-19 en pediatría: a un año de pandemia

inferred← citeshttps://doi.org/10.35381/s.v.v5i1.1595openalex-snapshot

Ivermectina como alternativa de tratamiento para pacientes COVID-19

inferred← citeshttps://doi.org/10.35587/brj.ed.0001334openalex-snapshot

PROMOÇÃO DE HÁBITOS SAUDÁVEIS DE VIDA PARA HIPERTENSOS USANDO GRUPOS OPERATIVOS, NA ATENÇÃO PRIMÁRIA EM SAÚDE

inferred← citeshttps://doi.org/10.35587/brj.ed.0001336openalex-snapshot

ACOMPANHAMENTO FARMACOTERAPÊUTICO NOS CUIDADOS PALIATIVOS: ASSISTÊNCIA AO PACIENTE PEDIÁTRICO?

inferred← citeshttps://doi.org/10.35839/repis.4.3.747openalex-snapshot

COVID-19 y la “locura” por la ivermectina

inferred← citeshttps://doi.org/10.36829/63cts.v7i3.1002openalex-snapshot

La acelerada búsqueda de candidatos terapéuticos contra SARS-CoV-2, métodos in silico: Revisión

inferred← citeshttps://doi.org/10.36829/63cts.v7i3.976openalex-snapshot

Evidencia disponible sobre el abordaje terapéutico de pacientes con COVID-19: una revisión narrativa

inferred← citeshttps://doi.org/10.36959/577/493openalex-snapshot

Natural Experiments that Allow to Study Potential Drugs in Coronavirus Disease 2019 (COVID-19) from the General Practice Level

inferred← citeshttps://doi.org/10.38137/vetfarmatoksbulten.769889openalex-snapshot

COVID-19 FARMAKOTERAPİSİ

inferred← citeshttps://doi.org/10.4103/ecdt.ecdt_30_21openalex-snapshot

Efficacy of ivermectin in patients with coronavirus disease 2019 pneumonia with severe and critically ill status

inferred← citeshttps://doi.org/10.4103/ijoem.ijoem_460_20openalex-snapshot

COVID-19—Practicing prevention in the workplace

inferred← citeshttps://doi.org/10.4103/mamcjms.mamcjms_77_21openalex-snapshot

Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19

inferred← citeshttps://doi.org/10.4103/mjmsr.mjmsr_19_21openalex-snapshot

Drug interactions of ivermectin with a focus on COVID-19 treatment

inferred← citeshttps://doi.org/10.46295/2:1.covrevopenalex-snapshot

The five axes of COVID-19 treatment: attacking the disease from several angles.

inferred← citeshttps://doi.org/10.46912/wjmbs.2openalex-snapshot

As Drugs Assemble to Treat SARS-COV-2, Which Drug will Prove Efficacious : A Search for Suitable Drug or Vaccine to Manage COVID-19 Pandemic

inferred← citeshttps://doi.org/10.47992/ijhsp.2581.6411.0060openalex-snapshot

An Overview of Drugs Used in COVID-19: A Pharmacotherapeutic Approach

inferred← citeshttps://doi.org/10.48550/arxiv.2005.05954openalex-snapshot

COVID-19Base: A knowledgebase to explore biomedical entities related to COVID-19

inferred← citeshttps://doi.org/10.51699/ijbea.v3i1.3296openalex-snapshot

Role of Ivermectin and Colchicine in Treatment of COVID-19: A Randomized Controlled Clinical Trial

inferred← citeshttps://doi.org/10.51723/ccs.v31isuppl1.693openalex-snapshot

Abordagem profilática da nitazoxanida e ivermectina na COVID-19: Sumário de Evidências

inferred← citeshttps://doi.org/10.51891/rease.v7i5.1208openalex-snapshot

TRATAMENTO FARMACOLÓGICO DA COVID-19 À LUZ DAS EVIDÊNCIAS: OS PRINCIPAIS FÁRMACOS, SUAS INDICAÇÕES E SEU MANEJO TERAPÊUTICO, UMA REVISÃO INTEGRATIVA

inferred← citeshttps://doi.org/10.51952/9781447363972.ch012openalex-snapshot

Conducting ethical research in crisis situations: COVID-19

inferred← citeshttps://doi.org/10.52225/narra.v2i3.92openalex-snapshot

A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

inferred← citeshttps://doi.org/10.5377/rmh.v89i1.11577openalex-snapshot

COVID-19 y protocolo MAÍZ como tratamiento profiláctico en Honduras, 2020: Artículo de revisión

inferred← citeshttps://doi.org/10.53854/liim-2903-2openalex-snapshot

Current status of therapeutic alternatives for COVID-19: A narrative review

inferred← citeshttps://doi.org/10.54139/salus.v25i3.125openalex-snapshot

Uso de compuestos potencialmente tóxicos en el contexto de la pandemia por COVID-2019.

inferred← citeshttps://doi.org/10.5530/jppcm.2020.4.19openalex-snapshot

Unapproved Combination Therapy of Doxycycline and Ivermectin in Covid-19 Pandemic, an Opportunistic Chance of Self-medication: A Case Report

inferred← citeshttps://doi.org/10.56687/9781447363972-010openalex-snapshot

Ethical research in public policy

inferred← citeshttps://doi.org/10.61186/jcbior.3.3.172openalex-snapshot

A comprehensive review of novel coronavirus disease 2019 (nCOVID-19) characteristics, diagnosis, treatment, and prevention

inferred← citeshttps://doi.org/10.63845/3gw6kd57openalex-snapshot

COVID-19, ASPECTOS GERAIS E A TRAJETÓRIA DO VÍRUS NO ESTADO DE SANTA CATARINA

inferred← citeshttps://doi.org/10.64461/hjps.v01i01y23.02openalex-snapshot

Comparative clinical management, treatment pattern and medications of COVID-19 practiced at Dhaka city in Bangladesh: a randomized cross-sectional study

inferred← citeshttps://doi.org/10.70675/cf058269z5911z4582z94fezcb6761f74dddopenalex-snapshot

Impact of Listeria monocytogenes on microglia and cerebral homeostasis

inferred← citeshttps://doi.org/10.7322/abcshs.2021069.2004openalex-snapshot

Main aspects and prophylatic measures of COVID-19 in Brazil

inferred← citeshttps://doi.org/10.7759/cureus.26141openalex-snapshot

Ivermectin-Induced Acute Psychosis in Patients Infected With COVID-19 Pneumonia

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.